Free Trial

Privia Health Group (NASDAQ:PRVA) Stock Price Crosses Above 200 Day Moving Average - Should You Sell?

Privia Health Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Shares of Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $22.63 and traded as high as $23.98. Privia Health Group shares last traded at $23.94, with a volume of 3,338,673 shares.

Privia Health Group News Summary

Here are the key news stories impacting Privia Health Group this week:

Analyst Upgrades and Downgrades

PRVA has been the topic of a number of recent research reports. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Privia Health Group in a research report on Tuesday, September 29th. Citigroup restated a "buy" rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Zacks Research upgraded shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a research report on Wednesday, August 5th. Finally, Canaccord Genuity Group set a $32.00 target price on Privia Health Group in a report on Friday, August 7th. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Privia Health Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $31.00.

Check Out Our Latest Report on PRVA

Privia Health Group Trading Up 6.9%

The business's 50 day simple moving average is $20.97 and its 200 day simple moving average is $22.63. The firm has a market capitalization of $3.06 billion, a PE ratio of 114.01 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.12. The business had revenue of $656.96 million during the quarter, compared to analyst estimates of $610.72 million. Privia Health Group had a return on equity of 3.52% and a net margin of 1.19%. The company's revenue for the quarter was up 13.2% on a year-over-year basis. During the same period last year, the company earned $0.29 EPS. Analysts forecast that Privia Health Group, Inc. will post 0.27 earnings per share for the current year.

Hedge Funds Weigh In On Privia Health Group

A number of large investors have recently bought and sold shares of the business. Public Employees Retirement System of Ohio bought a new position in Privia Health Group in the 2nd quarter worth about $26,000. Heritage Family Offices LLP purchased a new stake in shares of Privia Health Group during the 3rd quarter worth $34,000. Parallel Advisors LLC boosted its holdings in shares of Privia Health Group by 313.7% in the 3rd quarter. Parallel Advisors LLC now owns 2,180 shares of the company's stock valued at $43,000 after buying an additional 1,653 shares in the last quarter. Allworth Financial LP purchased a new position in Privia Health Group in the second quarter worth $48,000. Finally, Nykredit A S purchased a new position in Privia Health Group during the 2nd quarter worth $50,000. Hedge funds and other institutional investors own 94.48% of the company's stock.

About Privia Health Group

(Get Free Report)

Privia Health Group, Inc is a physician-enablement company that partners with independent medical practices to support the delivery of coordinated, value-based care. The company provides an integrated platform designed to help physicians manage clinical, administrative and financial functions while maintaining ownership and control of their practices.

Its services include practice management, electronic health record and technology support, revenue-cycle management, payer contracting, population-health analytics, care-management programs and administrative assistance.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Privia Health Group Right Now?

Before you consider Privia Health Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.

While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines